Post‒COVID-19 condition, also referred to as long COVID or post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) among other names, is a condition characterized by new or persisting symptoms beyond the acute phase of the disease (e.g., for more than 4 or 12 weeks following an initial COVID-19 infection, clinical definition pending). People with post‒COVID-19 may experience a range of heterogenous symptoms including fatigue, shortness of breath, muscle aches, and cognitive and mental health challenges.
Although the clinical pathophysiology of the condition is not yet well-defined, it is increasingly being recognized that it affects multiple organs and may have severe impacts to a person’s well-being and quality of life.
CADTH is conducting a scoping review to examine the current evidence landscape related to post‒COVID-19 conditions by mapping the literature and identifying research gaps. Current clinical classification, prevention, screening, and treatment for post‒COVID-19 conditions are increasingly of interest for this review.
Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies and expected completion dates may change. Find out more about Projects in Progress.
The “Projects in Progress” page on the CADTH website is updated on a seven- to eight-day cycle. Please be advised that there may be overlap between when a new report is posted online and when the section is updated. View our current Projects in Progress.